Cargando…

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

SIMPLE SUMMARY: Most glioblastoma patients succumb to the disease within 12 to 18 months, and only 9% are alive 2 years after diagnosis. Even with extensive research, the life expectancy of glioblastoma patients has not changed in decades. We aimed to identify differences in the transcriptomic profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303503/ https://www.ncbi.nlm.nih.gov/pubmed/34298634 http://dx.doi.org/10.3390/cancers13143419

Ejemplares similares

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020)

Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
por: Colja, Sara, et al.
Publicado: (2023)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
por: Samec, Neja, et al.
Publicado: (2018)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018)

Current Technologies for RNA-Directed Liquid Diagnostics
por: Martinez-Dominguez, Maria Victoria, et al.
Publicado: (2021)

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019)

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021)

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
por: Zottel, Alja, et al.
Publicado: (2023)

OligoPrime: An Information System for Oligonucleotide Management
por: Ravnik, Šimen, et al.
Publicado: (2021)

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
por: Kamashev, Dmitrii, et al.
Publicado: (2022)

Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy
por: Kiraly, Peter, et al.
Publicado: (2021)

Mutations in Collagen Genes in the Context of an Isolated Population
por: Zupan, Andrej, et al.
Publicado: (2020)

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022)

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers
por: Skoblar Vidmar, Marija, et al.
Publicado: (2022)

Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level
por: Raevskiy, Mikhail, et al.
Publicado: (2022)

Stereotactic radiosurgery for patients with breast cancer brain oligometastases — molecular subtypes and clinical outcomes
por: Ratosa, Ivica, et al.
Publicado: (2021)

Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas
por: Konovalov, Nikolay, et al.
Publicado: (2022)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021)

Glioblastoma in Patients over 70 Years of Age
por: Smrdel, Uros, et al.
Publicado: (2018)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
por: Jovčevska, Ivana, et al.
Publicado: (2017)

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023)

Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth
por: Kamashev, Dmitry, et al.
Publicado: (2021)

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021)

Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)

Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling
por: Lebedev, Timofey, et al.
Publicado: (2022)

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
por: Jeromen, Ana, et al.
Publicado: (2012)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways
por: Sorokin, Maxim, et al.
Publicado: (2021)

Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3‐Crnde negative feedback in diabetic cardiomyopathy
por: Zheng, Dezhi, et al.
Publicado: (2019)

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
por: Zakharova, Galina, et al.
Publicado: (2022)

RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report
por: Seryakov, Alexander, et al.
Publicado: (2021)

Differences between human and chimpanzee genomes and their implications in gene expression, protein functions and biochemical properties of the two species
por: Suntsova, Maria V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dt9iia5ej035vg501d2pvbvmdt